Chinook Therapeutics Presents Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) and Atrasentan Program at the American Society of Nephrology (ASN) Kidney Week 2021

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access